Laboratory Animal Short Course
Following the conference at Niagara-on-the-Lake, CanCog will be offering a laboratory animal short course for veterinary behavior residents at the research site in Fergus, Ontario, on November 4th and 5th.
Program *
Saturday, Nov 4th
Seminar
Fergus, Ontario Facility
Introduction to Transpharmation and CanCog Research facilities and
models
Laboratory animal veterinary medicine and biomedical research
Animal care and use, and laboratory practices in animal research
Principles of experimental design
Cross-species use of tethered vs telemetered EEG assessment to assess
translational drug action
Dog and cat models in CDS and Alzheimer’s Disease
Dog and cat models of situational (state) fear, anxiety and stress
Sunday, Nov 5th
Workshop, Seminars, and Tour
Fergus, Ontario Facility
Rodent care, housing and laboratory models of research
The operant rodent platform – what is it all about?
Canine neuropsychological models for cognitive assessment
Monday, Nov 6th
Tour
University of Toronto, Mississauga
Morning optional visit (space-limited) to the University of Toronto
Mississauga (UTM) laboratory research facilities
Registration
Includes:
- Laboratory Animal Course at the Fergus research facility on November 4th and 5th.
- Lunch on November 4th and 5th
- Optional tour of the University of Toronto Mississauga Research facilities on Monday morning, November 6th
Does Not Include:
- Transportation to and from facilities (shared car rental is recommended)
- Accommodations
- Meals outside those listed
Workshop Instructors *
Shawn Davis MSc, DVM, Dip (Path)
Veterinary Director UTM and Consulting Veterinarian, Transpharmation Canada
Gary Landsberg DVM, DACVB, DECAWBM
Veterinary Scientific Director, CanCog Inc.
Bill Milgram PhD
Founder and Chairman of the Board, CanCog Inc.
Christina de Rivera MSc
Chief Scientific Officer - Transpharmation Canada and CanCog Inc.
Joseph Araujo BSc
Founder and CEO CanCog Inc., Chief Corporate Development Officer
Sandor Kantor PhD
Scientific Director, Transpharmation Ltd.
Guy Higgins PhD
Chief Scientific Officer, Transpharmation Ltd.
*Program is tentative and subject to change.
